PATENT CLAIM ANALYSIS

Application Number: 15974909
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "249000"]

Abstract:
A novel process for improving neurochemical health includes a multi-day treatment program including intravenous delivery of nicotinamide adenine dinucleotide (NAD) to at least partially restore a patient's brain to a desired chemical balance. Intravenous delivery of NAD is synergistically combined with delivery of selected amino acids and, depending on the ailment being treated, a combination of ozone, testosterone, glutathione, Myers cocktail or other specified compounds.

Claim (Index 19):
The method of  claim 8 , further comprising providing to the patient at least one of acupuncture treatment, chiropractic adjustment, testosterone replacement therapy, massages, application of pain cream, ozone therapy, UV light therapy, and oral supplements of niacin and NAD.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15298735', '12119911', '14624376', '09632838', '15015796']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7312812779975926
- 35 USC 102 Novelty (BERT): 0.4756759147706226
- Combined Prediction Score: 0.7057207416748956
- Mean Citation Score: 142.362718
- Max Citation Score: 152.9796
- Similarity Product: 109.724652968359

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test